Company Search:
Advanced Search
Sponsored Links
Gtx, Inc. Company Snapshot
Gtx, Inc. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Gtx with three other companies in this sector in the United States: Theravance Biopharma Inc (2011 sales of $14.85 million of which 100% was Human Therapeutics), Pacira Pharmaceuticals Inc ($15.69 million of which 100% was Depo Foam Drug Delivery Technology), and Cymabay Therapeutics Inc ($15.15 million ).

Sales Analysis. Sales fell dramatically in 2011: Gtx reported sales of $14.74 million for the year ending December of 2011. This represents a sharp decrease of 75.7% versus 2010, when the company's sales were $60.61 million.
  Stock Performance Chart for Gtx, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): .78
(Figures in U.S. Dollars)
1 Week -7.1%   13 Weeks 10.2%  
4 Weeks 36.8%   52 Weeks -16.1%  
Gtx, Inc. Key Data:
  Ticker: GTXI Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2011 Sales 14,739,000
(Year Ending Jan 2012).
Employees: 29
  Currency: U.S. Dollars Market Cap: 110,694,337
  Fiscal Yr Ends: December Shares Outstanding: 141,915,817
  Share Type: Common Closely Held Shares: 114,369,310
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.